MAVERICS Trademark

Trademark Overview


On Monday, December 10, 2018, a trademark application was filed for MAVERICS with the United States Patent and Trademark Office. The USPTO has given the MAVERICS trademark a serial number of 88223551. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, October 11, 2019. This trademark is owned by Medical 21, Inc.. The MAVERICS trademark is filed in the Medical Instrument Products category with the following description:

Synthetic vascular grafts
maverics

General Information


Serial Number88223551
Word MarkMAVERICS
Filing DateMonday, December 10, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, October 11, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesSynthetic vascular grafts

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, January 2, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMedical 21, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPlymouth, MN 55447

Trademark Events


Event DateEvent Description
Friday, October 11, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, October 11, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, March 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 14, 2019NON-FINAL ACTION E-MAILED
Thursday, March 14, 2019NON-FINAL ACTION WRITTEN
Thursday, March 7, 2019ASSIGNED TO EXAMINER
Wednesday, January 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 13, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords


maverics grafts vascular synthetic